No significant differences in FZD2 expression were observed in UCEC, cervical squamous cell carcinoma (CESC), THCA, READ, acute lymphoblastic leukemia (ALL), or pheochromocytoma and paraganglioma (PCPG) (Figure 2B). Here, FZD2 is linked to acute lymphoblastic leukemia.